Sphera Funds Management Ltd. Chemomab Therapeutics Ltd. Transaction History
Sphera Funds Management Ltd.
- $380 Million
- Q1 2025
A detailed history of Sphera Funds Management Ltd. transactions in Chemomab Therapeutics Ltd. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 900,428 shares of CMMB stock, worth $1.04 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
900,428
Previous 1,214,575
25.86%
Holding current value
$1.04 Million
Previous $2.45 Million
60.01%
% of portfolio
0.26%
Previous 0.51%
Shares
2 transactions
Others Institutions Holding CMMB
# of Institutions
18Shares Held
3.72MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA1.74MShares$2.02 Million0.06% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3578KShares$670,8170.12% of portfolio
-
Ikarian Capital, LLC Dallas, TX213KShares$247,1400.03% of portfolio
-
Morgan Stanley New York, NY117KShares$135,9050.0% of portfolio
-
Kestra Private Wealth Services, LLC31.2KShares$36,2390.0% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $13.3M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...